非酶糖基化对α-synuclein分子构象的影响

被引：9

作者：

盛之玲

刘延英

陈岚

赫荣乔

机构：

[1] 中国科学院生物物理研究所

来源：

生物化学与生物物理进展 | 2008年 / 10期

基金：

中国科学院基金;

关键词：

非酶糖基化; α-synuclein; 分子构象; 特征荧光; 错误折叠; 分子聚集; 神经退行性疾病;

D O I：

暂无

中图分类号：

R341 [];

学科分类号：

摘要：

将纯化后的α-synuclein分别与果糖和葡萄糖孵育,通过内源荧光、非酶糖基化衍生物特征荧光、圆二色光谱以及电子显微镜等技术进行检测发现:α-synuclein与还原糖共同孵育后,308nm内源荧光强度明显降低,同时在447nm产生一个非酶糖基化衍生物特征荧光.与果糖孵育的蛋白质样品其非酶糖基化特征荧光的出现速度快于葡萄糖孵育样品.内源荧光与非酶糖基化特征荧光之间存在能量传递现象,提示Tyr残基与非酶糖基化特征荧光发色团在空间距离上彼此接近.圆二色光谱测定结果显示,α-synuclein与果糖孵育后,其α-螺旋含量增加.非酶糖基化的α-synuclein在电子显微镜下表现为短纤维状.非酶糖基化可以诱导α-synuclein蛋白分子聚集,且果糖较葡萄糖更容易使α-synuclein发生非酶糖基化.以上结果提示,非酶糖基化似乎可以导致α-synuclein在细胞内的错误折叠和分子聚集.

引用

页码：1202 / 1208

页数：7

共 13 条

[1]

Physiological and pathological properties of α-synuclein [J].

Tofaris, G. K. ;

Spillantini, M. G. .

CELLULAR AND MOLECULAR LIFE SCIENCES, 2007, 64 (17) :2194-2201

[2]

α-Synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers [J].

Beyer, Katrin .

ACTA NEUROPATHOLOGICA, 2006, 112 (03) :237-251

[3]

A new method for purification of recombinant human α-synuclein in Escherichia coli [J].

Huang, CJ ;

Ren, GP ;

Zhou, H ;

Wang, CC .

PROTEIN EXPRESSION AND PURIFICATION, 2005, 42 (01) :173-177

[4]

Glycoxidation and Diabetic Complications: Modern Lessons and a Warning?.[J].Helen Vlassara;Jaime Uribarri.Reviews in Endocrine and Metabolic Disorders.2004, 3

[5]

Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification [J].

Schalkwijk, CG ;

Stehouwer, CDA ;

van Hinsbergh, VWM .

DIABETES-METABOLISM RESEARCH AND REVIEWS, 2004, 20 (05) :369-382

[6]

Parkinson's Disease.[J].William Dauer;Serge Przedborski.Neuron.2003, 6

[7]

Parkinson's disease and related neurodegenerative synucleinopathies linked to progressive accumulations of synuclein aggregates in brain [J].

Trojanowski, JQ ;

Lee, VMY .

PARKINSONISM & RELATED DISORDERS, 2001, 7 (03) :247-251

[8]

Advanced glycation end-products: a review [J].

Singh, R ;

Barden, A ;

Mori, T ;

Beilin, L .

DIABETOLOGIA, 2001, 44 (02) :129-146

[9]

Crosslinking of α-synuclein by advanced glycation endproducts — an early pathophysiological step in Lewy body formation?.[J].G. Münch;H.J. Lüth;A. Wong;Th. Arendt;E. Hirsch;R. Ravid;P. Riederer.Journal of Chemical Neuroanatomy.2000, 3

[10]

Activation of receptor for advanced glycation end products - A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis [J].

Schmidt, AM ;

Yan, SD ;

Wautier, JL ;

Stern, D .

CIRCULATION RESEARCH, 1999, 84 (05) :489-497

← 1 2 →